Quipt Home Medical (QIPT) Stock Forecast, Price Target & Predictions
QIPT Stock Forecast
Quipt Home Medical stock forecast is as follows: an average price target of $6.00 (represents a 148.96% upside from QIPT’s last price of $2.41) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
QIPT Price Target
The average price target for Quipt Home Medical (QIPT) is $6.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $6.00. This represents a potential 148.96% upside from QIPT's last price of $2.41.
QIPT Analyst Ratings
According to 2 Wall Street analysts, Quipt Home Medical's rating consensus is 'Buy'. The analyst rating breakdown for QIPT stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Quipt Home Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 16, 2024 | Richard Close | Canaccord Genuity | $6.00 | $2.74 | 118.98% | 148.96% |
| May 17, 2024 | Richard Close | Canaccord Genuity | $8.00 | $3.20 | 150.00% | 231.95% |
The latest Quipt Home Medical stock forecast, released on Aug 16, 2024 by Richard Close from Canaccord Genuity, set a price target of $6.00, which represents a 118.98% increase from the stock price at the time of the forecast ($2.74), and a 148.96% increase from QIPT last price ($2.41).
Quipt Home Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 2 |
| Avg Price Target | - | - | $7.00 |
| Last Closing Price | $2.41 | $2.41 | $2.41 |
| Upside/Downside | -100.00% | -100.00% | 190.46% |
In the current month, the average price target of Quipt Home Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Quipt Home Medical's last price of $2.41. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 20, 2024 | Benchmark | Buy | Buy | Hold |
| May 17, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| May 16, 2024 | Raymond James | Underperform | Downgrade |
Quipt Home Medical's last stock rating was published by Benchmark on May 20, 2024. The company gave QIPT a "Buy" rating, the same as its previous rate.
Quipt Home Medical Financial Forecast
Quipt Home Medical Revenue Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | $67.17M | $62.52M | - | $58.12M | $40.81M | $40.09M | $36.69M | $33.55M | $29.52M | $29.12M | $26.24M | $24.24M | $22.75M | $19.77M | $18.94M | $16.99M | $17.43M | $11.85M | $16.09M |
| Avg Forecast | $68.89M | $67.76M | $66.39M | $64.88M | $64.92M | $65.06M | $65.59M | $64.45M | $62.88M | $59.97M | $57.09M | $42.19M | $40.39M | $36.48M | $34.47M | $30.27M | $27.96M | $26.90M | $24.84M | $22.77M | $20.51M | $19.63M | $17.16M | $18.36M | $15.75M | $17.08M |
| High Forecast | $70.60M | $69.45M | $68.42M | $66.12M | $65.67M | $66.68M | $67.22M | $65.03M | $64.00M | $61.47M | $58.51M | $43.24M | $40.39M | $36.48M | $34.47M | $30.27M | $27.96M | $26.90M | $24.84M | $22.77M | $20.51M | $19.63M | $17.16M | $18.36M | $15.75M | $17.08M |
| Low Forecast | $67.95M | $66.84M | $65.26M | $64.21M | $64.18M | $64.17M | $64.69M | $63.51M | $61.79M | $59.15M | $56.31M | $41.61M | $40.39M | $36.48M | $34.47M | $30.27M | $27.96M | $26.90M | $24.84M | $22.77M | $20.51M | $19.63M | $17.16M | $18.36M | $15.75M | $17.08M |
| # Analysts | 1 | 1 | 3 | 3 | 2 | 1 | 2 | 3 | 6 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Surprise % | - | - | - | - | - | - | - | 1.04% | 0.99% | - | 1.02% | 0.97% | 0.99% | 1.01% | 0.97% | 0.98% | 1.04% | 0.98% | 0.98% | 1.00% | 0.96% | 0.96% | 0.99% | 0.95% | 0.75% | 0.94% |
Quipt Home Medical's average Quarter revenue forecast for Mar 24 based on 2 analysts is $65.59M, with a low forecast of $64.69M, and a high forecast of $67.22M. QIPT's average Quarter revenue forecast represents a -2.35% decrease compared to the company's last Quarter revenue of $67.17M (Dec 23).
Quipt Home Medical EBITDA Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 2 | 1 | 2 | 3 | 6 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| EBITDA | - | - | - | - | - | - | - | $14.28M | $16.09M | - | $17.59M | $10.71M | $11.48M | $9.71M | $14.32M | $6.05M | $5.20M | $8.65M | $668.00K | $7.18M | $3.66M | $6.02M | $4.90M | $6.71M | $4.42M | $1.83M |
| Avg Forecast | $10.95M | $10.77M | $10.55M | $10.31M | $10.32M | $10.34M | $10.42M | $10.24M | $9.99M | $9.53M | $9.07M | $6.70M | $9.86M | $8.91M | $26.65M | $7.39M | $6.83M | $14.67M | $6.06M | $5.56M | $5.01M | $4.79M | $4.19M | $4.48M | $3.84M | $4.17M |
| High Forecast | $11.22M | $11.04M | $10.87M | $10.51M | $10.44M | $10.60M | $10.68M | $10.33M | $10.17M | $9.77M | $9.30M | $6.87M | $9.86M | $8.91M | $31.98M | $7.39M | $6.83M | $17.61M | $6.06M | $5.56M | $5.01M | $4.79M | $4.19M | $4.48M | $3.84M | $4.17M |
| Low Forecast | $10.80M | $10.62M | $10.37M | $10.20M | $10.20M | $10.20M | $10.28M | $10.09M | $9.82M | $9.40M | $8.95M | $6.61M | $9.86M | $8.91M | $21.32M | $7.39M | $6.83M | $11.74M | $6.06M | $5.56M | $5.01M | $4.79M | $4.19M | $4.48M | $3.84M | $4.17M |
| Surprise % | - | - | - | - | - | - | - | 1.39% | 1.61% | - | 1.94% | 1.60% | 1.16% | 1.09% | 0.54% | 0.82% | 0.76% | 0.59% | 0.11% | 1.29% | 0.73% | 1.26% | 1.17% | 1.50% | 1.15% | 0.44% |
2 analysts predict QIPT's average Quarter EBITDA for Mar 24 to be $10.42M, with a high of $10.68M and a low of $10.28M. This is -27.02% lower than Quipt Home Medical's previous annual EBITDA (Dec 23) of $14.28M.
Quipt Home Medical Net Income Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 2 | 1 | 2 | 3 | 6 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Net Income | - | - | - | - | - | - | - | $-602.20K | $-1.33M | - | $-9.50M | $325.00K | $1.77M | $163.00K | $5.04M | $-2.13M | $-1.50M | $6.33M | $-20.85M | $-2.97M | $-1.67M | $-2.73M | $1.16M | $-6.20M | $2.95M | $-9.55M |
| Avg Forecast | $5.93M | $5.08M | $4.30M | $3.59M | $-1.05M | $-466.34K | $385.62K | $-847.45K | $-96.22K | $-94.13K | $1.79M | $-1.20M | $1.17M | $1.65M | $12.09M | $1.32M | $-1.28M | $8.44M | $2.05M | $846.63K | $3.29M | $-4.68M | - | $1.71M | $6.93M | $-16.98M |
| High Forecast | $6.12M | $5.25M | $4.44M | $3.71M | $599.64K | $-458.05K | $395.25K | $282.48K | $-94.51K | $-92.45K | $1.85M | $-1.18M | $1.17M | $1.65M | $14.50M | $1.32M | $-1.28M | $10.13M | $2.05M | $846.63K | $3.29M | $-4.68M | - | $1.71M | $6.93M | $-16.98M |
| Low Forecast | $5.82M | $4.99M | $4.22M | $3.53M | $-2.40M | $-481.45K | $375.99K | $-1.69M | $-99.34K | $-97.18K | $1.76M | $-1.24M | $1.17M | $1.65M | $9.67M | $1.32M | $-1.28M | $6.75M | $2.05M | $846.63K | $3.29M | $-4.68M | - | $1.71M | $6.93M | $-16.98M |
| Surprise % | - | - | - | - | - | - | - | 0.71% | 13.78% | - | -5.31% | -0.27% | 1.51% | 0.10% | 0.42% | -1.61% | 1.17% | 0.75% | -10.18% | -3.51% | -0.51% | 0.58% | - | -3.62% | 0.43% | 0.56% |
Quipt Home Medical's average Quarter net income forecast for Mar 23 is $1.79M, with a range of $1.76M to $1.85M. QIPT's average Quarter net income forecast represents a 450.10% increase compared to the company's last Quarter net income of $325.00K (Dec 22).
Quipt Home Medical SG&A Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 2 | 1 | 2 | 3 | 6 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| SG&A | - | - | - | - | - | - | - | $34.49M | $1.37M | - | $27.95M | $20.03M | $897.00K | $18.25M | $17.42M | $15.52M | $16.66M | $13.10M | $10.54M | $9.46M | $9.20M | $7.73M | $7.55M | $8.12M | $6.12M | $7.60M |
| Avg Forecast | $18.49M | $18.19M | $17.82M | $17.42M | $17.43M | $17.47M | $17.61M | $17.30M | $16.88M | $16.10M | $15.33M | $11.33M | $11.92M | $10.77M | $10.18M | $8.93M | $8.25M | $17.47M | $7.33M | $6.72M | $6.05M | $5.79M | $5.07M | $5.42M | $4.65M | $5.04M |
| High Forecast | $18.95M | $18.64M | $18.37M | $17.75M | $17.63M | $17.90M | $18.05M | $17.46M | $17.18M | $16.50M | $15.71M | $11.61M | $11.92M | $10.77M | $10.18M | $8.93M | $8.25M | $20.96M | $7.33M | $6.72M | $6.05M | $5.79M | $5.07M | $5.42M | $4.65M | $5.04M |
| Low Forecast | $18.24M | $17.94M | $17.52M | $17.24M | $17.23M | $17.23M | $17.37M | $17.05M | $16.59M | $15.88M | $15.12M | $11.17M | $11.92M | $10.77M | $10.18M | $8.93M | $8.25M | $13.97M | $7.33M | $6.72M | $6.05M | $5.79M | $5.07M | $5.42M | $4.65M | $5.04M |
| Surprise % | - | - | - | - | - | - | - | 1.99% | 0.08% | - | 1.82% | 1.77% | 0.08% | 1.69% | 1.71% | 1.74% | 2.02% | 0.75% | 1.44% | 1.41% | 1.52% | 1.33% | 1.49% | 1.50% | 1.32% | 1.51% |
Quipt Home Medical's average Quarter SG&A projection for Mar 24 is $17.61M, based on 2 Wall Street analysts, with a range of $17.37M to $18.05M. The forecast indicates a -48.95% fall compared to QIPT last annual SG&A of $34.49M (Dec 23).
Quipt Home Medical EPS Forecast
| Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 3 | 3 | 2 | 1 | 2 | 3 | 6 | 4 | 4 | 2 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| EPS | - | - | - | - | - | - | - | $-0.02 | $-0.03 | - | $-0.26 | $0.01 | $0.05 | - | $0.15 | $-0.06 | $-0.05 | $0.20 | $-0.71 | $-0.11 | $-0.08 | $-0.13 | $0.06 | $-0.30 | $0.14 | $-0.46 |
| Avg Forecast | $0.14 | $0.12 | $0.10 | $0.08 | $-0.02 | $-0.01 | $0.01 | $-0.02 | $-0.00 | $-0.00 | $0.04 | $-0.03 | $0.03 | $0.04 | $0.01 | $0.03 | $-0.03 | $0.04 | $0.05 | $0.02 | $0.08 | $-0.11 | - | $0.04 | $0.16 | $-0.40 |
| High Forecast | $0.14 | $0.12 | $0.10 | $0.09 | $0.01 | $-0.01 | $0.01 | $0.01 | $-0.00 | $-0.00 | $0.04 | $-0.03 | $0.03 | $0.04 | $0.01 | $0.03 | $-0.03 | $0.04 | $0.05 | $0.02 | $0.08 | $-0.11 | - | $0.04 | $0.16 | $-0.40 |
| Low Forecast | $0.14 | $0.12 | $0.10 | $0.08 | $-0.06 | $-0.01 | $0.01 | $-0.04 | $-0.00 | $-0.00 | $0.04 | $-0.03 | $0.03 | $0.04 | $0.01 | $0.03 | $-0.03 | $0.04 | $0.05 | $0.02 | $0.08 | $-0.11 | - | $0.04 | $0.16 | $-0.40 |
| Surprise % | - | - | - | - | - | - | - | 0.77% | 13.29% | - | -6.20% | -0.36% | 1.82% | 0.13% | 25.47% | -2.06% | 1.61% | 4.87% | -14.78% | -5.54% | -1.03% | 1.18% | - | -7.46% | 0.86% | 1.15% |
According to 4 Wall Street analysts, Quipt Home Medical's projected average Quarter EPS for Mar 23 is $0.04, with a low estimate of $0.04 and a high estimate of $0.04. This represents a 319.45% increase compared to QIPT previous annual EPS of $0.01 (Dec 22).
Quipt Home Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| TELA | TELA Bio | $2.76 | $8.00 | 189.86% | Buy |
| QIPT | Quipt Home Medical | $2.61 | $6.00 | 129.89% | Buy |
| LUNG | Pulmonx | $6.13 | $13.00 | 112.07% | Buy |
| PROF | Profound Medical | $7.24 | $15.17 | 109.53% | Buy |
| SGHT | Sight Sciences | $3.62 | $7.50 | 107.18% | Hold |
| RXST | RxSight | $38.04 | $70.14 | 84.38% | Buy |
| KIDS | OrthoPediatrics | $22.46 | $39.50 | 75.87% | Buy |
| OFIX | Orthofix Medical | $17.93 | $24.00 | 33.85% | |
| NPCE | NeuroPace | $11.52 | $15.00 | 30.21% | Buy |
| PRCT | PROCEPT BioRobotics | $88.56 | $105.00 | 18.56% | Buy |
| FNA | Paragon 28 | $10.36 | $11.50 | 11.00% | Buy |
| CVRX | CVRx | $13.16 | $14.25 | 8.28% | Buy |
| AORT | Artivion | $28.90 | $30.75 | 6.40% | Buy |
| SRDX | Surmodics | $39.96 | $39.50 | -1.15% | Buy |